Let's be honest. The US patent system was never designed for cannabis. And trying to force cannabis into that system may not be the right approach.
For a long time, I approached cannabis from a purely biological perspective. It's a plant. It should be treated like other agricultural crops. In many ways, that's true. But cannabis doesn't exist only as a biological system. Its history and culture tell a different story.
Cannabis has shaped human society for centuries, possibly longer. It has existed simultaneously as medicine, ritual, commodity, and contraband. Because of that, it developed outside of traditional agricultural and legal frameworks. It built its own ecosystem, its own economy, and its own way of moving through the world.
That history matters when we talk about genetics and ownership.
In most crops, new cultivars move through formal systems. There are records, registries, and timelines that align reasonably well with regulatory structures. Cannabis didn't develop that way. For decades, genetics moved through informal networks, passed hand to hand as clones, shared among growers, traded within communities. There were no paper trails, no timestamps, no documentation. That wasn't a failure of responsibility. It was a function of prohibition.
At the same time, cannabis markets move fast. A new cultivar can gain traction across an entire region, or even nationally, in a matter of months. Consumer demand can spread quickly. A single cut can go from unknown to widely cultivated in a single season.
This is where the mismatch becomes obvious.
The US patent system operates on a timescale of years. Cannabis genetics move on a timescale of weeks to months. Expecting breeders to delay releasing a cultivar while waiting for patent approval means asking them to give up momentum, visibility, and often significant revenue. In cannabis, timing is not a minor detail. It is often the difference between success and irrelevance.
On top of that, the patent process is expensive, slow, and not easily accessible, particularly for independent breeders and smaller operators. For a crop that spent decades in a legal gray area, those barriers are even more pronounced.
So the question becomes: if the existing system doesn't fit, what does?
Genetic documentation offers an alternative that operates on a timescale aligned with the industry. DNA fingerprinting can be completed in days to weeks. A genotype can be recorded, timestamped, and associated with a specific cultivar at the point of release. That information can then be incorporated into contracts, licensing agreements, and material transfer agreements.
This doesn't replace legal frameworks, but it supports them. It provides a way to document identity and establish a reference point without requiring breeders to wait for a system that was never designed for this crop or this market.
More importantly, it reflects how cannabis actually functions.
Cannabis is not just another agricultural product. It is a crop shaped by culture, constrained by history, and accelerated by modern markets. Any system intended to support it needs to account for those realities.
Rather than trying to adapt cannabis to fit an existing structure, it may be more practical to build infrastructure that fits cannabis.
Genetic verification and documentation are one step in that direction.
Research foundation
- Schwabe and McGlaughlin, Cannabis strain reliabilityPeer-reviewed publication
- Schwabe et al., comparative genetic structurePeer-reviewed publication
- Jin et al., classification of cannabis strainsPeer-reviewed publication